Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SupCHO: Supplemental Choline for Early Iron Deficiency
NCT06527391Phase 3Recruiting
- Sponsor
- University of Minnesota
- Start
- Aug 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of choline in iron deficiency anemia (IDA) (2 arms), sponsored by University of Minnesota. Primary endpoints: Elicited Imitation at 9 months, Mullen Scales of Early Learning Composite at 9 months and 2 more. Started Aug 2025; status: recruiting.
02
Drugs
choline
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06527391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06527391.